🇺🇸 FDA
Pipeline program

Miyarisan-BM (Clostridium Butyricum Miyairi)

KMUHIRB-F(I)-20220001

Unknown small_molecule active

Quick answer

Miyarisan-BM (Clostridium Butyricum Miyairi) for Clostridium Butyricum Miyairi is a Unknown program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Clostridium Butyricum Miyairi
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials